EMA recommends approval of second adapted Spikevax vaccine

View source ↗

Summary

EMA recommends approval of a second adapted Spikevax vaccine, expanding options for booster protection against evolving SARS-CoV-2 variants.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronavirus Disease 2019

Drugs mentioned

• Spikevax (mRNA-1273)